Relation
@RelationRx
Followers
1K
Following
503
Media
27
Statuses
202
Discovering the relationships at the heart of biology to cure disease
London
Joined August 2020
We were deeply honoured to have Sir Paul Nurse @TheCrick join us to officially open our flagship integrated dry-wet lab in London's @KQ_London . Thank you Sir Paul Nurse for your inspirational speech and joining our CEO @welshmanofkent inaugurating our magnificent new home!
0
2
25
At @raais 2025, Benjamin Swerner Co-Founder and COO of @RelationRx reflected on why this century will be defined by two breakthroughs: building intelligence independent of humans and reducing the world’s disease burden. Be part of the community at raais(dot)co, rsvps open!
0
2
3
This is an amazing line up! Come one and all :D
High-Content CRISPR Screening Conference March 18-19, 2026 | Vienna, Austria Abstract submission is now open! Don’t miss the chance to hear from an outstanding line-up of speakers and connect with leading researchers in the field. Register now: https://t.co/PS5qma07iu
0
1
4
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18–19, 2026, in Vienna, Austria. The registration is now open via the website: https://t.co/PS5qma0F82 Meet the Speaker: Jake P. Taylor-King @wildtypehuman
@RelationRx
1
2
6
AI is accelerating the future of medicine. NVIDIA is collaborating with healthcare and life sciences leaders across the UK to unlock faster, more precise drug discovery. From Hologen’s complex human biology models and @RelationRx lab-in-the-loop experimentation, to @InSilicoUK’s
2
6
15
Making AI useful in the lab: the missing math of active learning A call for greater first-principles theory to power lab-in-the-loop science with @BlackHC and @paulmorio
3
25
159
With Paul Scherer of @RelationRx and Andreas Kirsch (@BlackHC) we give our take on how to exploit a very simple relationship (the bias-variance tradeoff) to build a class of general AL strategies. https://t.co/druOzLSkH2
arxiv.org
Real-world experimental scenarios are characterized by the presence of heteroskedastic aleatoric uncertainty, and this uncertainty can be correlated in batched settings. The bias--variance...
1
4
25
Much of the active learning literature avoids modelling the bias and noise of the underlying experimental system...
4
21
184
Relationships That Make TechBio Go 'Round. Listen to David Roblin, CEO of @RelationRx on The Long Run.
timmermanreport.com
David Roblin is today’s guest on The Long Run podcast. David is the CEO of London-based Relation Therapeutics. The company uses multi-omic tools to look for drug targets in human tissue samples. It...
0
2
4
I love seeing @RelationRx's term "lab-in-the-loop" making it into the modern parlance!
Lab-in-the-loop therapeutic antibody design At @PrescientDesign @genentech we have spent 3+ years reimagining drug discovery. We built a machine learning system to design and execute experiments. Here's how it works and what we can do 🧵 1/
0
2
7
Read the @scTrends_update take on the AI arms race to generate single-cell data https://t.co/2GfiRhwzEW Thanks @AdamCribbs !
sctrends.org
AI-scale data generation, new tech, latest News and M&A.
0
6
10
How big a market do early stage VCs think there actually is for protein foundation models? Remember, the key cost and hurdle is clinical trails, not a lack of molecules to try drugging people with. (Side note: we need new targets and that's what @RelationRx is about)
i wonder if, after every new protein foundation company starts up, the vc's that invested in the last one longingly look at the new one and then back to the one they invested in. "did i make the right choice?" they think. "that new one has deepmind people...", they muse, "...but
1
3
19
🚀 Have You Read the UK biotech financing report yet? ➡️ https://t.co/NKoL7SSH2U Our latest #UKbiotech financing report is packed with inspiring case studies of groundbreaking companies securing funding to drive 🚀 innovation, fuel R&D, and strengthen the UK’s position as a
0
1
1
@RelationRx in the news! Thoughtful report of our investor @DCVC @jason_pontin along with a review of biotech financing in the UK by the @BIA_UK
Thrilled to be featured in the @BIA_UK report on UK biotech financing and also highlighted in the @DCVC 2024 report. ➡️@DCVC report: TechBio and data-centric AI https://t.co/BjTconriLH ➡️ @BIA_UK 2024 report: https://t.co/GsjHuZX886
0
2
1
New preprint -- https://t.co/jKSv50ALAZ Old school math bio treatment of perturbation prediction! #CRISPR #singlecell CC - @RelationRx @doctordindsay @CarolineUhler @TriendlHagenRel @thomasgaudelet
arxiv.org
Despite substantial efforts, deep learning has not yet delivered a transformative impact on elucidating regulatory biology, particularly in the realm of predicting gene expression profiles. Here,...
0
7
15
Thrilled to be featured in the @BIA_UK report on UK biotech financing and also highlighted in the @DCVC 2024 report. ➡️@DCVC report: TechBio and data-centric AI https://t.co/BjTconriLH ➡️ @BIA_UK 2024 report: https://t.co/GsjHuZX886
0
1
2
The honour was all ours @jason_pontin @DCVC . Thank you for joining us, providing such deep insights and for your sponsorship to the event. Raising money for @DamonRunyon via the @ldtimmerman Traverse. 💥👏🏽
My colleagues and I have long seen TechBio—the data-centric, AI-native counterweight to biotech—as a major opportunity area for AI applications. @DCVC portfolio co @RelationRx, whose lab-in-the-loop model is working toward creating life-changing treatments for complex,
0
0
3
Fantastic to have you join us @ldtimmerman , and what a great cause! 🥼🧫🤖🧬🗻
Hello, London! I'm excited to join this Jan. 29 conference @TheCrick on tech-driven drug discovery. Organized by Rosie Rodriguez @RelationRx. All proceeds go to high-risk/high-reward cancer research @DamonRunyon Register:
0
1
4
Hello, London! I'm excited to join this Jan. 29 conference @TheCrick on tech-driven drug discovery. Organized by Rosie Rodriguez @RelationRx. All proceeds go to high-risk/high-reward cancer research @DamonRunyon Register:
luma.com
Code to cure: London's TechBio Revolution We are thrilled to invite you to kick off 2025 with a landmark event in TechBio innovation. London's TechBio…
0
2
7
Back to AIdrugX #NeurIPS2024 workshop to catch a fantastic panel on AI & new drug modalities! With @thisismadani @ProfluentBio, @lecong @Stanford, @gracexyzheng @ArsenalBio, @SeeligLab, and @HesselEdith @RelationRx.
0
2
7
Incredibly delighted to be part of the Kennedy Trust Board. The high quality work and people funded by the trust paves the way to new therapeutic opportunities for patients! @TheKennedyTrust @KirOxford
We’re delighted to welcome four new Trustees to the Kennedy Trust’s Board: Professor Paul Peter Tak @paulpetertak, Dr Edith Hessel @HesselEdith, Professor Paul Emery and Dr Tony Wood! Read more on our website 👇 https://t.co/xvDlwEkME5
0
1
6